Alignment Healthcare (ALHC) director awarded 13,096 restricted stock units

Rhea-AI Filing Summary

KOSECOFF JACQUELINE B reported acquisition or exercise transactions in this Form 4 filing.

Alignment Healthcare, Inc. director Jacqueline B. Kosecoff reported an equity grant of 13,096 shares of Common Stock in the form of restricted stock units. These RSUs were awarded at no cash cost to her as a standard grant, not an open-market purchase.

Each restricted stock unit represents one share of Common Stock and will fully vest on the one-year anniversary of the grant date, assuming she continues to serve on the Board of Directors through that date. Following this grant, she directly holds 303,963 shares, including the new award.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider KOSECOFF JACQUELINE B

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	13,096	$0.00	--

Holdings After Transaction: Common Stock — 303,963 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KOSECOFF JACQUELINE B

(Last) (First) (Middle)

1100 W. TOWN & COUNTRY RD.

SUITE 1600

(Street)

ORANGE CA 92868

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Alignment Healthcare, Inc. [ ALHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/13/2026		A		13,096(1)	A	$0	303,963	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents 13,096 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date.

Remarks:

	/s/ Christopher J. Joyce, as Attorney-in-Fact, for Jacqueline B. Kosecoff	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did ALHC director Jacqueline Kosecoff report?

Director Jacqueline B. Kosecoff reported receiving 13,096 restricted stock units of Alignment Healthcare Common Stock. The award was granted at no cash cost as part of her director compensation and represents a routine equity grant rather than an open-market share purchase.

How many Alignment Healthcare shares does Jacqueline Kosecoff hold after this Form 4?

After the reported grant, Jacqueline Kosecoff directly holds 303,963 shares of Alignment Healthcare Common Stock. This total includes the 13,096 restricted stock units awarded, each representing the right to receive one share when the units vest under the grant terms.

When do Jacqueline Kosecoff’s new ALHC restricted stock units vest?

All 13,096 restricted stock units granted to Jacqueline Kosecoff vest on the one-year anniversary of the grant date. Vesting is contingent on her continued service on Alignment Healthcare’s Board of Directors through that date, so departure earlier would prevent full vesting.

Was cash paid for the ALHC shares reported in this Form 4?

No cash was paid for these Alignment Healthcare shares. The Form 4 shows a grant of 13,096 restricted stock units at a reported price of $0.0000 per share, reflecting an equity award as compensation rather than a purchase on the open market.

What does the restricted stock unit grant mean for ALHC shareholders?

The grant adds 13,096 potential shares tied to director compensation at Alignment Healthcare. These units convert into Common Stock only if vesting conditions are met, aligning director incentives with long-term company performance without involving an immediate market transaction or cash movement.